These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2014467)

  • 21. [Agranulocytosis caused by captopril: report of a case].
    Ochoa Gómez FJ; Andrés Nilsson C; Salcedo Aguilar J; Campo Hernández JM; Peña Somovilla JL; Márquez de Prado M
    An Med Interna; 1989 Feb; 6(2):109-10. PubMed ID: 2491070
    [No Abstract]   [Full Text] [Related]  

  • 22. [Agranulocytosis associated with captopril 2 new cases].
    Zylberait D; Veyssier P; Di Guilio S; Grunfeld JP
    Nouv Presse Med; 1982 May; 11(25):1952. PubMed ID: 7050899
    [No Abstract]   [Full Text] [Related]  

  • 23. Captopril--an overview.
    Rosendorff C
    S Afr Med J; 1982 Oct; 62(17):593-9. PubMed ID: 6214858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe neutropenia following a prolonged course of vancomycin that progressed to agranulocytosis with drug reexposure.
    Duff JM; Moreb JS; Muwalla F
    Ann Pharmacother; 2012 Jan; 46(1):e1. PubMed ID: 22170976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe reversible azotemia from captopril therapy. Report of three cases and review of the literature.
    Chrysant SG; Dunn M; Marples D; DeMasters K
    Arch Intern Med; 1983 Mar; 143(3):437-41. PubMed ID: 6338847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Captopril-induced agranulocytosis].
    López Aldeguer J; Catalá J; Sanz MA
    Med Clin (Barc); 1988 Feb; 90(5):218-9. PubMed ID: 3280900
    [No Abstract]   [Full Text] [Related]  

  • 28. Severe side-effects of captopril in advanced chronic kidney insufficiency.
    Beroniade V
    Proc Eur Dial Transplant Assoc; 1983; 20():530-7. PubMed ID: 6228942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
    Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
    Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Agranulocytosis induced by captopril].
    Gómez-Martino Arroyo JR; Jorquera Plaza F; Ordóñez González R; Granda Rodríguez M
    An Med Interna; 1989 Jul; 6(7):387-8. PubMed ID: 2491496
    [No Abstract]   [Full Text] [Related]  

  • 31. Side effects of angiotensin converting enzyme inhibitor (captopril) in newborns and young infants.
    Gantenbein MH; Bauersfeld U; Baenziger O; Frey B; Neuhaus T; Sennhauser F; Bernet V
    J Perinat Med; 2008; 36(5):448-52. PubMed ID: 18605972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haematological side effects of clozapine: patient characteristics.
    Miller PR; Cutten AE
    N Z Med J; 1997 Apr; 110(1041):125-7. PubMed ID: 9140414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deterioration in renal function in patients with chronic renal failure after treatment with captopril.
    Boner G; Morduchowicz G; Rotenberg Z; Weinberger I; Shohat J; Rosenfeld JB
    Isr J Med Sci; 1985 Nov; 21(11):892-4. PubMed ID: 3908397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Severe side-effects of captopril].
    Arcavi L; Estrov Z; Caspi A; Resnitzky P
    Harefuah; 1985 May; 108(9):439-41. PubMed ID: 3896985
    [No Abstract]   [Full Text] [Related]  

  • 35. [Reversible renal insufficiency and arterial hypertension after renal transplantation: role of transplant artery stenosis and a captopril-furosemide combination].
    Suc JM; Vernier I; Durand D; Giraud P; Segonds-Modesto A; Sarramon JP
    Nephrologie; 1985; 6(3):155-8. PubMed ID: 3908959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mianserin: a possible cause of neutropenia and agranulocytosis. Adverse Drug Reactions Advisory Committee.
    Med J Aust; 1980 Dec; 2(12):673-4. PubMed ID: 7219304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Side effects induced by captopril. Comparison of a series of hypertensive patients with renal failure and a series with cardiac failure].
    Kayanakis JG; Doat P; Grenet B; Albagnac N; Fauvel JM; Durand D; Suc JM; Bounhoure JP
    Arch Mal Coeur Vaiss; 1983 Sep; 76(9):1065-71. PubMed ID: 6227300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enalapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Vlasses PH; Larijani GE; Conner DP; Ferguson RK
    Clin Pharm; 1985; 4(1):27-40. PubMed ID: 2982541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Reversible panmyelopathy following captopril treatment].
    Iro H; Henschke F; König HJ
    Dtsch Med Wochenschr; 1986 Jan; 111(4):139-41. PubMed ID: 3510849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Reversible deterioration of renal function, skin exanthema and eosinophilia, in a female patient with chronic kidney insufficiency, after treatment with captopril].
    Gómez-Martino Arroyo JR; Giménez García RM; Rodríguez Prieto MA; Mateos Polo L
    Rev Clin Esp; 1989 May; 184(9):497. PubMed ID: 2528187
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.